March 2023
NIH Technology Opportunities Webinar: Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
Register to attend a free NIH webinar. Attendees will learn about a new method for treating glaucoma using exosomes derived from bone marrow-derived mesenchymal stem cells (BMSC). The webinar will be presented by Dr. Stanislav Tomarev (Senior Investigator, Retinal Ganglion Cell Biology, NIH National Eye Institute) and Dr. Ben Mead (Neuroscientist, Cardiff University Exosome and Retinal Research Group). Webinar overview: The inventors will discuss their discovery that BMSC‐derived exosome administration for glaucoma may confer a significant neuroprotective effect for retinal…
Find out more »November 2023
NCI Technology Opportunity Webinar: Automated Acoustophoresis Device to Radio-Label & Isolate Cells for Immunotherapy Treatment
Register to attend a free NIH webinar. Attendees will learn about the research behind a proposed new automated bench-top device for labeling immunotherapy cells with 89Zr-oxine for Positron Emission Tomography (PET) tracking during treatment. The current method for labeling cells with 89Zr-oxine involves a tedious manual process requiring several rounds of centrifugation and pipetting from a highly skilled technician. However, even with a technician’s high skill level, the process suffers from low reproducibility and reliability of labeled cells. Dr. Adler…
Find out more »